Post by Clement on Feb 15, 2024 7:20:44 GMT -5
MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza
finance.yahoo.com/news/mannkind-announces-enrollment-goal-completion-110500790.html
Reached enrollment goal of 305 patients living with Type 1 or Type 2 diabetes
Primary endpoint analysis expected in 4Q 2024
Data dissemination and FDA submission expected in 2025
finance.yahoo.com/news/mannkind-announces-enrollment-goal-completion-110500790.html
Reached enrollment goal of 305 patients living with Type 1 or Type 2 diabetes
Primary endpoint analysis expected in 4Q 2024
Data dissemination and FDA submission expected in 2025